How to define the therapeutic limits
Submitted: May 16, 2017
Accepted: May 16, 2017
Published: July 18, 2017
Accepted: May 16, 2017
Abstract Views: 1042
PDF: 508
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- A. Chetta, M. Aiello, P. Tzani, D. Olivieri, Assessment and monitoring of ventilatory function and cough efficacy in patients with amyotrophic lateral sclerosis , Monaldi Archives for Chest Disease: Vol. 67 No. 1 (2007): Pulmonary series
- Eugenio Laurenzano, Lucrezia Spadera, Mario De Laurentis, Gregorio Brevetti, Impairment of microcirculation and energy metabolism in intermittent claudication: beneficial effects of exercise training , Monaldi Archives for Chest Disease: Vol. 72 No. 3 (2009): Cardiac series
- Donatella Del Sindaco, Maria Denitza Tinti, Giovanni Pulignano, Stefano Tolone, Giovanni Minardi, Massimo Uguccioni, Antonio Lax, Cardiac rehabilitation is safe and effective also in the elderly, but don't forget about drugs! , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Giuseppe Caramia, Romualdo Belardinelli, Hyperhomocysteinemia in developing age and nutritional aspects of folates: an early cardiovascular risk factor , Monaldi Archives for Chest Disease: Vol. 66 No. 4 (2006): Cardiac series
- Margaret Cupples, Neil Heron, What to do after cardiac rehabilitation programs: the role of the general practitioner in cardiovascular prevention , Monaldi Archives for Chest Disease: Vol. 86 No. 1-2 (2016): Cardiac series
- A.E. Erbaycu, Z. Taymaz, F. Tuksavul, A. Afrashi, S.Z. Güçlü, What happens when oral tuberculosis is not treated? , Monaldi Archives for Chest Disease: Vol. 67 No. 2 (2007): Pulmonary series
- Giusy Sirico, Lucrezia Spadera, Mario De Laurentis, Gregorio Brevetti, Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation , Monaldi Archives for Chest Disease: Vol. 72 No. 1 (2009): Cardiac series
- Stefano Fumagalli, Serena Boni, Simone Pupo, Marta Migliorini, Irene Marozzi, Eleonora Barghini, Flavia Sacco, Niccolò Marchionni, Rate-control vs rhythm-control of atrial fibrillation in elderly patients. From new, age-oriented outcomes to a more complex management strategy , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- I. Chkhaidze, T. Maglakelidze, N. Khaltaev, Chronic respiratory diseases at primary health care level in Georgia: the results of the pilot study , Monaldi Archives for Chest Disease: Vol. 71 No. 4 (2009): Pulmonary series
- Sotirios Moraitis, Dimitrios Moraitis, Maria Chounti, Panagiotis Hountis, Aneurysmal rib cyst , Monaldi Archives for Chest Disease: Vol. 87 No. 3 (2017)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
You may also start an advanced similarity search for this article.